Evidence map›Paper›PMID 40535340›Full record

ArticleFrontiers in endocrinology2025

Effect of COVID-19 inactivated vaccine on anti-Müllerian hormone in Chinese women: a retrospective cohort study.

Mingjie Bao, Leizhen Xia, Yan Ling, Quan Wen, Xin Shen, Ting Wang, Si Qian, Liqun Wang, Changhua Wang, Shiwei Peng and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mingjie Bao *Department of Obstetrics and Gynecology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Leizhen Xia *Department of Reproductive Medicine, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
Yan Ling *Department of Obstetrics and Gynecology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Quan WenDepartment of Obstetrics and Gynecology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Xin ShenDepartment of Obstetrics and Gynecology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Ting WangDepartment of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
Si QianDepartment of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
Liqun WangDepartment of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
Changhua WangDepartment of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
Shiwei PengDepartment of Obstetrics and Gynecology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Yongping ZhangDepartment of Obstetrics and Gynecology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Shaoping ZhongDepartment of Obstetrics and Gynecology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.
Hongying XuDepartment of Gynecology, Jiangxi Maternal and Child Health Hospital, Nanchang, China.
Yuan ZhuDepartment of Obstetrics and Gynecology, Jiangxi Provincial People's Hospital, The First Affiliated Hospital of Nanchang Medical College, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study aimed to assess the impact of inactivated COVID-19 vaccine on Anti-Müllerian hormone (AMH) levels in Chinese women. Methods: A retrospective analysis was conducted on women aged 18-45 who had undergone two AMH tests between March 2020 and September 2021. Participants were grouped based on vaccine doses (two- and three-dose), time intervals since vaccination, and manufacturers. The difference in AMH levels and the percentage changes in AMH were measured. Results: The results revealed no significant differences in AMH levels between the vaccinated groups (two- and three-dose) and the control group, both in unadjusted and adjusted analyses. Subgroup analysis showed no statistical difference in either absolute or percentage changes of AMH levels among different time-interval groups and manufacturer groups. Discussion: In conclusion, the number of doses, time interval, and manufacturer of the inactivated COVID-19 vaccine did not affect AMH levels in Chinese women.

Indexed as

Anti-Mullerian HormoneCOVID-19COVID-19 VaccinesAdolescentAdultChinaEast Asian PeopleFemaleHumansMiddle AgedRetrospective StudiesVaccines, InactivatedYoung AdultAnti-Mullerian HormoneCOVID-19 VaccinesSARS-CoV-2 inactivated vaccinesVaccines, Inactivatedanti-Müllerian hormoneCOVID-19 inactivated vaccineCOVID-19 vaccineovarian reservereproductive health

Identifiers

PMID40535340
PMCPMC12173908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.